WS #13445
Holding: newest synthesis is 107d 23h old
Novo Nordisk raised guidance but analysts unimpressed, with oral Wegovy and CagriSema results mixed, intensifying competition with Eli Lilly.
Novo Nordisk guidance and competition
Novo Nordisk raised guidance but analysts unimpressed, with oral Wegovy and CagriSema results mixed, intensifying competition with Eli Lilly.